BRPI0715728A2 - treatment of cartilaginous disorder - Google Patents

treatment of cartilaginous disorder

Info

Publication number
BRPI0715728A2
BRPI0715728A2 BRPI0715728-2A2A BRPI0715728A BRPI0715728A2 BR PI0715728 A2 BRPI0715728 A2 BR PI0715728A2 BR PI0715728 A BRPI0715728 A BR PI0715728A BR PI0715728 A2 BRPI0715728 A2 BR PI0715728A2
Authority
BR
Brazil
Prior art keywords
treatment
cartilaginous disorder
cartilaginous
disorder
Prior art date
Application number
BRPI0715728-2A2A
Other languages
Portuguese (pt)
Inventor
Alberto Gimona
Christoph H Ladel
Elmar Vom Baur
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2007/058830 external-priority patent/WO2008023063A2/en
Publication of BRPI0715728A2 publication Critical patent/BRPI0715728A2/en
Publication of BRPI0715728A8 publication Critical patent/BRPI0715728A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0715728A 2006-08-25 2007-08-24 treatment of cartilage disorders BRPI0715728A8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (2)

Publication Number Publication Date
BRPI0715728A2 true BRPI0715728A2 (en) 2013-09-17
BRPI0715728A8 BRPI0715728A8 (en) 2018-04-03

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715728A BRPI0715728A8 (en) 2006-08-25 2007-08-24 treatment of cartilage disorders

Country Status (11)

Country Link
CN (1) CN101505787B (en)
BR (1) BRPI0715728A8 (en)
DK (1) DK2054050T3 (en)
ES (1) ES2392883T3 (en)
MY (1) MY148277A (en)
NZ (1) NZ574216A (en)
PT (1) PT2054050E (en)
RS (1) RS52710B (en)
SI (1) SI2054050T1 (en)
UA (1) UA99818C2 (en)
ZA (1) ZA200900426B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104736723B (en) * 2012-08-06 2017-10-31 默克专利有限公司 Genetic marker for predicting the response to the compounds of FGF 18
MX2016010873A (en) * 2014-02-20 2016-11-17 Merck Patent Gmbh Fgf-18 in graft transplantation and tissue engineering procedures.
US9889179B2 (en) * 2014-02-20 2018-02-13 Merck Patent Gmbh FGF-18 compound dosing regimen
CA2938796C (en) * 2014-02-20 2022-08-02 Merck Patent Gmbh Implant comprising fgf-18
WO2016112176A1 (en) * 2015-01-08 2016-07-14 University Of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
EP3957654A1 (en) * 2015-07-15 2022-02-23 Prosit Sole Biotechnology (Beijing) Co., Ltd Fusion polypeptides and methods of use
RU2745453C2 (en) * 2015-08-13 2021-03-25 Мерк Патент Гмбх Combined composition containing fgf-18 compound
EP4061836A4 (en) * 2019-11-21 2024-02-14 Remedium Bio, Inc. Growth factor restoration
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (en) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 mRNA for treating osteoarthritis and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003279835B2 (en) * 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
CA2592044A1 (en) * 2004-07-06 2006-02-09 Zymogenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
CA2592261C (en) * 2004-12-10 2015-11-24 Zymogenetics Inc. Fgf18 production in prokaryotic hosts

Also Published As

Publication number Publication date
CN101505787B (en) 2013-09-04
DK2054050T3 (en) 2012-09-03
SI2054050T1 (en) 2012-12-31
MY148277A (en) 2013-03-29
NZ574216A (en) 2011-11-25
PT2054050E (en) 2012-09-17
ES2392883T3 (en) 2012-12-14
ZA200900426B (en) 2010-04-28
CN101505787A (en) 2009-08-12
UA99818C2 (en) 2012-10-10
RS52710B (en) 2013-08-30
BRPI0715728A8 (en) 2018-04-03

Similar Documents

Publication Publication Date Title
BRPI0811265A2 (en) TREATMENT OF SYNUCLEINOPATHIES
DK2982696T3 (en) TREATMENT OF ACUTE Lymphoblastogenic Infections
DK1986633T3 (en) TREATMENT OF DUCHENNES MUSCLE DYSTROPHY
BRPI0715728A2 (en) treatment of cartilaginous disorder
BRPI0910854A2 (en) treatment methods
DK2222272T3 (en) Treatment of respiratory disease
CR10841A (en) IMIDAZOTRIAZINAS IMIDAZOPIRIMIDINAS INHIBIDORES DE CINASA
DE602007004361D1 (en) endoscope system
DK2350116T3 (en) BIOFILM TREATMENT
BRPI0815551A2 (en) TREATMENT THROUGH HUCBC OF BETA-AMYLOID DISEASE
DK2373927T3 (en) WASTE TREATMENT OF WASTE TREATMENT
DK2173831T3 (en) WELL TREATMENT
BRPI0821652A2 (en) biofuel treatment
BRPI0814876A2 (en) PHOSPHORILATED PYRONA ANALOGS AND METHODS
BRPI0812087A2 (en) FORMS FORMATION OF SILENT FORMS
BRPI0916079A2 (en) wastewater treatment
DK2117565T3 (en) APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES
DK2056858T3 (en) TREATMENT OF LUNG DISEASE CONDITIONS
LTC2066352I2 (en) Treatment of Multiple Sclerosis (MS) with Campan-1H
DK2175849T3 (en) Treatment of melanomas
DK2190451T3 (en) TREATMENT OF ATHEROSCLEROSIS
BRPI0811625A2 (en) COGNITIVE DISORDER TREATMENT METHODS THROUGH GPR12 INHIBIT
DK2323686T3 (en) Adiponectin for the treatment of lung disease
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
DK2222289T3 (en) TREATMENT OF ORAL PHARYNGEAL DYSPHAGI

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]